环铂治疗播散性前列腺癌患者
[Cycloplatam in the treatment of patients with disseminated prostatic cancer].
作者信息
Matveev B P, Gorbunova V A, Smirnova N B, Zhumagazin Zh D, Bukharkin B V, Orel N F
出版信息
Urol Nefrol (Mosk). 1996 May-Jun(3):34-6.
PMID:8928330
Abstract
A 22% response rate was achieved in clinical trials of Russian drug cycloplatam in disseminated and hormone-resistant cancer of the prostate. In 80% of cases the drug has improved quality of life of patients with prostatic cancer stage III and IV. Antitumor effect and low toxicity make cycloplatam applicable in combined therapy of prostatic cancer.
摘要
俄罗斯药物环铂在前列腺播散性和激素抵抗性癌症的临床试验中实现了22%的缓解率。在80%的病例中，该药物改善了III期和IV期前列腺癌患者的生活质量。环铂的抗肿瘤作用和低毒性使其适用于前列腺癌的联合治疗。
Zotero 插件